Class I ยท High risk
MitoXANTRONE Injection
Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.
National Drug Code
Is NDC 61703-0343-65 recalled?
Mitoxantrone · 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65) / 12.5 mL in 1 VIAL, MULTI-DOSE
Yes — this exact package was recalled
1 FDA recall names the code 61703-0343-65 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Mitoxantrone
- Strength
- MITOXANTRONE HYDROCHLORIDE 2 mg/mL
- Form
- Injection, Solution, Concentrate · Intravenous
- Labeler
- Hospira, Inc.
- Type
- Human Prescription Drug
- Product code
- 61703-0343
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 61703-0339 Carboplatin 4
- 61703-0360 Carboplatin 3
- 61703-0303 Cytarabine 1
- 61703-0327 See recall 1
- 61703-0332 Bleomycin 1
- 61703-0342 Paclitaxel 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.